Thank you for your interest in the CAB Lab. The lab is not accepting new members for the foreseeable future.
——-
In the Boettiger lab, our work focuses on improving our understanding of the neurobiology of substance use disorders (SUDs) by identifying and characterizing neurocognitive biomarkers and intermediate phenotypes. Recently, our work has approached this issue from two directions:
| 1. | Dissecting probable intermediate phenotypes, including: ♦ Immediate reward selection bias ♦ Enhanced habit learning ♦ Attentional bias toward reward-related cues |
| 2. | Identifying objective neurocognitive measures of addiction severity and therapeutic response. |
Through these approaches, we hope to realize more effective treatment and prevention strategies for substance use disorders (SUDs), which are the leading cause of preventable death in the U.S. Our techniques include combining discrete cognitive tasks in human subjects with neuroimaging, pharmacology, physiological and hormonal measures, genetics, and epigenetics.
We appreciate your interest in our work. At this time, we are not accepting inquiries regarding graduate student positions or undergraduate volunteer opportunities.